Scientists used CRISPR/Cas9 to disrupt the tyr and oca2 pigmentation genes in zebrafish, reducing melanophores and visibly ...

A new review finds CRISPR engineering can sharply raise carotenoid yields in microalgae, yet these gains mostly redistribute ...

Scientists have worked tirelessly to develop ever more precise and efficient CRISPR-Cas systems to reach the ultimate goal: safe and effective CRISPR-Cas-based medical treatments. Over the years, ...

Application of the high-precision technique is part of a clinical trial to treat a genetic disease that can cause liver and ...

Management's plan for the long term is to initiate one or two investigational new drug programs per year. That means it aims to start that many phase 1 trials of candidates that aren't already in its ...

Researchers at Biohub, an organisation backed by the Chan Zuckerberg Initiative co-founded by Priscilla Chan, have identified ...

Billionaire investor Cathie Wood, through her ARK ETFs, made big buys of CRISPR Therapeutics on Friday, Oct. 9, and Monday, ...

Human cells hold about two meters (6.6 feet) of DNA, folded and compacted to fit inside a nucleus. That packing is essential ...

Experts at the company don't know what the newfound system does, so its potential utility in biology—if any—remains unclear. But the work marks a major advancement because the A.I. made this discovery ...

CRISPR Therapeutics (NasdaqGM:CRSP) has promoted Andrew J. Silver to Chief Financial Officer, effective October 19, 2026.

Capitalize on ready-to-use CRISPR kits & enzymes and drug discovery demand with competitive insights, untapped market analysis, and go-to-market strategies.Dublin, Oct. (GLOBE NEWSWIRE) -- "CRISPR ...